Squadron Capital Management LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0002050709

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2026 Q2 2026 Q1 2026 Q4 2025

Q3 2026 · 38 positions · Total reported value $252.28M · Top-10 concentration 55.6% · Updated 2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

Turnover: 77.8% · 16 new · 10 cut · 16 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -5.7% · vs SPY -7.9% · Prev Value $255.55M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -9.0% · vs SPY -11.1% · Latest Value $252.28M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Squadron Capital Management LLC disclosed 38 equity positions with a combined reported value of $252.28M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 55.6% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were KOD ($25.60M), EWTX ($17.25M), RLAY ($14.17M). By sector, the heaviest allocations are Health Care 96.8%, Financials 1.4%. Versus the prior quarter, allocation shifted toward Financials (+1.4pp) and away from Health Care (-1.3pp).

Versus the prior quarter, Squadron Capital Management LLC opened 16 new positions, trimmed 10 and fully exited 16, a turnover rate of 77.8% of positions. The portfolio's overlap with the prior quarter was 41% of names.

The largest new positions opened in Q3 2026 were ORIC ($13.47M), PHVS ($12.69M), VERA ($9.85M).

Of the 16 positions fully exited versus the prior quarter, the largest were MAZE ($10.00M), ELVN ($8.12M), FBRX ($4.78M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • ORIC ORIC PHARMACEUTICALS INC · $13.47M
  • PHVS PHARVARIS N V · $12.69M
  • VERA VERA THERAPEUTICS INC · $9.85M
  • AVTX AVALO THERAPEUTICS INC · $6.90M
  • ACRS ACLARIS THERAPEUTICS INC · $6.31M
  • CBIO CRESCENT BIOPHARMA INC. · $5.11M
  • DARE YARROW BIOSCIENCE INC · $5.07M
  • ZURA ZURA BIO LTD · $4.99M

Fully Exited (vs previous quarter)

  • MAZE MAZE THERAPEUTICS INC · prev qtr: $10.00M
  • ELVN ENLIVEN THERAPEUTICS INC · prev qtr: $8.12M
  • FBRX FORTE BIOSCIENCES INC · prev qtr: $4.78M
  • IFRX INFLARX NV · prev qtr: $4.48M
  • PMN PROMIS NEUROSCIENCES INC · prev qtr: $4.28M
  • CMPS COMPASS PATHWAYS PLC · prev qtr: $4.25M
  • SLGL SOL-GEL TECHNOLOGIES LTD · prev qtr: $3.86M
  • PRQR PROQR THRAPEUTICS N V · prev qtr: $2.81M

Insider Transactions (Form 4)

Latest Squadron Capital Management LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Squadron Capital Management LLC, based in Oak Brook, IL, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 38 positions worth $252.28M in total. HoldingsHub carries 4 quarters of its filings (Q4 2025–Q3 2026).

Firm Snapshot

  • Headquarters: OAK BROOK, IL, United States
  • SEC registration: 801-136915 (status: Approved), registered 2026-08-05
  • Regulatory AUM (Form ADV): $385.68M as of 2026-06-29
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: squadroncapitalmgmt.com

Portfolio Structure

  • 38 positions · $252.28M reported value (Q3 2026)
  • Top 10 holdings = 55.6% of reported value
  • Largest position: KOD (KODIAK SCIENCES INC) at 10.1%
  • Average position size: $6.64M

Sector Tilt

  • Health Care 96.8%
  • Financials 1.4%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q3 2026: 16 new, 8 added, 10 reduced, 16 exited
  • 4 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 96.8%
Financials 1.4%
Other 1.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 270.00K $25.60M 10.15%
10.15%
Reduce
2 425.00K $17.25M 6.84%
6.84%
Add
3 785.00K $14.17M 5.62%
5.62%
Reduce
4 1.00M $13.47M 5.34%
5.34%
New
5 3.50M $13.20M 5.23%
5.23%
Reduce
6 340.00K $12.94M 5.13%
5.13%
Add
7 400.00K $12.69M 5.03%
5.03%
New
8 764.88K $12.24M 4.85%
4.85%
Hold
9 305.00K $9.85M 3.90%
3.90%
New
10 2.40M $8.86M 3.51%
3.51%
Reduce
11 134.50K $8.80M 3.49%
3.49%
Add
12 265.00K $8.49M 3.36%
3.36%
Reduce
13 450.00K $6.90M 2.73%
2.73%
New
14 1.20M $6.31M 2.50%
2.50%
New
15 1.32M $5.48M 2.17%
2.17%
Add
16 225.00K $5.29M 2.10%
2.10%
Add
17 1.62M $5.17M 2.05%
2.05%
Add
18 350.00K $5.11M 2.02%
2.02%
New
19 225.00K $5.07M 2.01%
2.01%
New
20 1.20M $4.99M 1.98%
1.98%
New
21 370.22K $4.63M 1.84%
1.84%
New
22 142.50K $4.31M 1.71%
1.71%
Reduce
23 2.00M $4.11M 1.63%
1.63%
Reduce
24 3.00M $4.05M 1.60%
1.60%
Hold
25 150.00K $3.74M 1.48%
1.48%
New
26 215.00K $3.72M 1.47%
1.47%
New
27 315.00K $3.49M 1.38%
1.38%
New
28 675.00K $3.48M 1.38%
1.38%
New
29 225.00K $3.02M 1.20%
1.20%
Reduce
30 90.00K $2.79M 1.11%
1.11%
Add
31 515.04K $2.54M 1.01%
1.01%
Reduce
32 180.00K $1.97M 0.78%
0.78%
New
33 1.40M $1.95M 0.77%
0.77%
New
34 810.00K $1.78M 0.71%
0.71%
Hold
35 250.00K $1.77M 0.70%
0.70%
Add
36 600.00K $1.45M 0.58%
0.58%
New
37 400.00K $1.33M 0.53%
0.53%
Hold
38 100.00K $277.00K 0.11%
0.11%
Reduce

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 60% R 60% F1 60% (modelled on 2026-Q2; 6/10 hit)

Low-confidence forecast This fund replaces about 37% of its Top-10 each quarter and backtests at F1 60% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (2 quarters)

Avg precision 60% · recall 60% · F1 60% · avg rank error 3.0 · Top-10 turnover 37%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2026-Q2 60% 60% 60% RLMD · COGT · KOD · ABVX · EWTX · NKTR · ANL · SCYX · MAZE · CCCC RLMD · COGT · KOD · RLAY · EWTX · MAZE · IVA · ANL · ELVN · AVBP
2026-Q3 ★ 60% 60% 60% RLMD · COGT · KOD · RLAY · EWTX · IVA · MAZE · ELVN · ANL · AVBP KOD · EWTX · RLAY · ORIC · RLMD · DFTX · PHVS · ANL · VERA · IVA

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-16. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-16 Trading days33 Holdings4 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.

Portfolio return-16.33%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+0.68%vs benchmark
Barra annualised vol59.8%Model estimate
Realised vol76.4%Annualised in window
Weighted beta1.39Raw exposure
Factor / specific risk50% / 50%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)78.485.091.798.3105.010-0110-2311-16Squadron Capital Management LLCQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)-16.33%Disclosed long book
QQQ synthetic benchmark-17.01%Liquidity-weighted constituents
Model universe, equal weight-1.70%Opportunity-cost reference
Excess return+0.68%Portfolio − benchmark
Arithmetic return sum-14.01%Difference vs compounded is the cross term
Weighted raw beta1.39Weighted holding betas
Realised volatility (annualised)76.36%Daily returns in window
Barra model volatility (annualised)59.77%Factor + specific
Factor share of variance50.4%Barra factors
Specific share of variance49.6%Stock residuals
Reported value$25.2M13F long US equity

2. Return attribution

The -14.01% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 -1.58% -11.3%
Momentum & Growth 3 -12.55% -89.6%
Volatility & Tail Risk 7 -1.77% -12.7%
Industry 12 +6.98% 49.9%
Specific 1 -5.09% -36.3%
Return attribution (style + industry, %)-12.2-6.1+0.0+6.1+12.2Max Drawdown-0.79Amihud Illiquidity-1.23Leverage (Downside Vol)-1.29Growth-1.78Kurtosis-1.81Turnover-2.04Beta+2.41Non-linear Size+3.10Size+3.23Mid Cap-5.17Health Care+6.98Residual Volatility+8.22Historical Volatility-8.88Momentum-11.28
Factor Type Exposure Factor return Contribution Share of |return|
Residual Volatility Style +2.50 +3.29% +8.22% 58.7%
Health Care Industry +1.00 +6.98% +6.98% 49.9%
Size Style -1.66 -1.95% +3.23% 23.1%
Non-linear Size Style +3.07 +1.01% +3.10% 22.1%
Beta Style +0.54 +4.44% +2.41% 17.2%
Liquidity Style +1.45 +0.36% +0.52% 3.7%
Short-term Reversal Style +0.58 +0.87% +0.51% 3.6%
Skewness Style -0.08 -4.39% +0.36% 2.6%
Max Drawdown Style +0.45 -1.76% -0.79% -5.7%
Amihud Illiquidity Style +2.75 -0.45% -1.23% -8.8%
Leverage (Downside Vol) Style +0.75 -1.71% -1.29% -9.2%
Growth Style -1.02 +1.75% -1.78% -12.7%
Kurtosis Style -0.24 +7.51% -1.81% -12.9%
Turnover Style +0.42 -4.80% -2.04% -14.5%
Specific Specific — — -5.09% -36.3%
Mid Cap Style +2.67 -1.94% -5.17% -36.9%
Historical Volatility Style +0.63 -14.00% -8.88% -63.4%
Momentum Style +2.82 -4.00% -11.28% -80.5%

3. Risk attribution

Annualised volatility is 59.77%; factor risk explains 50.4% of variance and specific risk 49.6%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-53.5-26.8+0.0+26.8+53.5Growth-1.87Max Drawdown+0.87Non-linear Size+0.99Historical Volatility+1.05Leverage (Downside Vol)+1.29Amihud Illiquidity+1.74Liquidity+3.33Beta+3.71Size+3.88Mid Cap+7.16Health Care+7.47Residual Volatility+8.08Momentum+12.06Specific+49.57
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 49.6% +29.63% 29.6%
Momentum Style +2.82 12.1% +7.21% 7.2%
Residual Volatility Style +2.50 8.1% +4.83% 4.8%
Health Care Industry +1.00 7.5% +4.46% 4.5%
Mid Cap Style +2.67 7.2% +4.28% 4.3%
Size Style -1.66 3.9% +2.32% 2.3%
Beta Style +0.54 3.7% +2.21% 2.2%
Liquidity Style +1.45 3.3% +1.99% 2.0%
Amihud Illiquidity Style +2.75 1.7% +1.04% 1.0%
Leverage (Downside Vol) Style +0.75 1.3% +0.77% 0.8%
Historical Volatility Style +0.63 1.1% +0.63% 0.6%
Non-linear Size Style +3.07 1.0% +0.59% 0.6%
Max Drawdown Style +0.45 0.9% +0.52% 0.5%
Short-term Reversal Style +0.58 0.5% +0.28% 0.3%
Growth Style -1.02 -1.9% -1.12% -1.1%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-2.1-0.70.72.13.5Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -1.66 +2.10 -3.76
Non-linear Size +3.07 +1.68 +1.39
Mid Cap +2.67 +0.13 +2.54
Beta +0.54 +1.29 -0.75
Momentum +2.82 +0.72 +2.10
Short-term Reversal +0.58 -0.64 +1.22
Residual Volatility +2.50 -0.40 +2.90
Historical Volatility +0.63 +0.86 -0.23
Liquidity +1.45 +0.11 +1.33
Amihud Illiquidity +2.75 +1.16 +1.60
Turnover +0.42 +0.21 +0.22
Growth -1.02 +0.58 -1.60
Leverage (Downside Vol) +0.75 +0.14 +0.61
Skewness -0.08 +0.24 -0.32
Kurtosis -0.24 +0.21 -0.46
Max Drawdown +0.45 -0.08 +0.53

5. Industry allocation & Brinson

Industry allocation (weight, %)-10.020.050.080.0110.0Information TechnologyCommunication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -22.33% +3.83% +16.44% -16.44% +16.44%
Communication Services 0.0% 2.6% +0.00% -17.64% +0.01% +0.46% -0.46% +0.46%
Utilities 0.0% 0.8% +0.00% +11.13% -0.22% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.26% -0.27% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +3.76% -1.84% -0.33% +0.33% -0.33%
Industrials 0.0% 11.1% +0.00% +4.36% -2.39% -0.48% +0.48% -0.48%
Health Care 100.0% 1.7% -16.80% +8.29% +24.98% -0.43% -24.65% -16.94%
Total +23.98% +15.41% -40.49% -1.10%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
RLAY RELAY THERAPEUTICS INC Health Care 56.12% -4.32% -2.43% Reduce
AVBP ARRIVENT BIOPHARMA INC Health Care 17.09% -61.82% -10.57% Reduce
TNGX TANGO THERAPEUTICS INC Health Care 14.82% -3.13% -0.46% New
CTNM CONTINEUM THERAPEUTICS INC Health Care 11.96% -27.94% -3.34% Reduce
Contribution rank Symbol Sector Weight Return Contribution
1 TNGX Health Care 14.82% -3.13% -0.46%
2 RLAY Health Care 56.12% -4.32% -2.43%
3 CTNM Health Care 11.96% -27.94% -3.34%
4 AVBP Health Care 17.09% -61.82% -10.57%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned -16.33%, versus -17.01% for the QQQ synthetic benchmark — an excess of +0.68%.
  2. Return attribution: the largest positive style/industry contributions came from Residual Volatility +8.22%, Health Care +6.98%, Size +3.23%; the largest drags came from Momentum -11.28%, Historical Volatility -8.88%, Mid Cap -5.17%. Specific (stock-level) return contributed -5.09%.
  3. Risk attribution: Barra model volatility is 59.77% annualised; factor risk explains 50% of variance and specific risk 50%. The largest factor risk sources are Momentum 12.1%, Residual Volatility 8.1%, Health Care 7.5%.
  4. Style tilt: size -1.66, momentum +2.82, volatility +0.63, liquidity +1.45; the weighted raw beta is 1.39. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+98.3 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +23.98%, selection +15.41% and interaction -40.49%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Squadron Capital Management LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, Squadron Capital Management LLC reported 38 equity positions worth $252.28M in aggregate; its largest disclosed positions were KOD ($25.60M), EWTX ($17.25M), RLAY ($14.17M).

How large is Squadron Capital Management LLC's portfolio?

Squadron Capital Management LLC reported $252.28M of long equity holdings across 38 positions as of 2026-Q3. Top-10 holdings account for 55.6% of reported value.

What is Squadron Capital Management LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/squadron-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →